List of voters for the quote

Most cannabis companies trading at nosebleed valuations are loss-making start-ups that are still trying to build out their distribution infrastructure and compliance, tPB already has the distribution, has a profitable core business with a proven management team, and has the regulatory background. If TPB traded at even a fraction of the valuation of other cannabis names, the stock would double overnight.

This page is about the voters of this citizen quote.